March 8th, 2007
Multiple myeloma is a cancer of the bone that currently has no cure.
In a new phase I clinical trial opened by Mayo Clinic Cancer Center, a bioengineered measles virus is being tested of its potential to kill cancer.
This the third of a series of molecular medicine studies in patients testing the potential of measles to kill […]
By Gloria Gamat -- 0 comments
March 6th, 2007
I think it’s always good to begin at the beginning. Even though our lives aren’t necessarily linear – there is always a story staring in the middle of another. But for each line in our life’s story there is a point where something else begins, right?
This part of my story starts June 7th even though […]
By Robin Dunn Bryant -- 10 comments
March 6th, 2007
A green tea polyphenol called epigallocatechin-3-gallate (EGCG) when combined with low doses of COX-2 inhibitor celecoxib, could slow the progression of human prostate cancer.
Such were the findings of researchers from University of Wisconsin-Madison reported in the March 1 issue of Clinical Cancer Research.
According to Hasan Mukhtar, Ph.D., professor of dermatology at the University of Wisconsin […]
By Gloria Gamat -- 0 comments
March 5th, 2007
The nonsurgical image-guided treatment of kidney tumors — cryoablation - - is as effective as the laparoscopic technique in viable candidates.
Such is the research finding recently reported at the Society of Interventional Radiology’s 32nd Annual Scientific Meeting.
The comparative trial shows that percutaneous cryoablation results in a slightly lower recurrence rate of the tumor, a shorter […]
By Gloria Gamat -- 0 comments
March 5th, 2007
A chemical, Bisphenol-A, an integral part of polycarbonate plastic, is found in a large array of products in the market.
Bisphenol-A is suspected to be link to cancer and other developmental problems in humans.
Since December 1, 2006, Francisco has banned the sale of all products made for children under 3 which contain Bisphenol-A – a new […]
By Gloria Gamat -- 0 comments
March 2nd, 2007
With a post in time for the Science and Health Channel Theme Day, you might have notice that this blog has a new blogger.
Yes folks, I am very happy to annouce that Robin Dunn Bryant will be my co-blogger here at Cancer Commentary.
Honestly, for long while now, we’ve been looking for someone like Robin to […]
By Gloria Gamat -- 2 comments
March 2nd, 2007
Viruses that can cause cells to fuse may lead to cancerous cells.
Fusion abruptly unites two or three cells under the same membrane, a change that triggers massive CIN and creates diverse cells whose properties change over time. The researchers found that some of these cells can become cancerous.
In the proposed model, identifying and inactivating […]
By Gloria Gamat -- 0 comments
March 2nd, 2007
Pittsburgh scientists have been able to synthesize a potent compound which works differently (at 10 ppb or parts per billion) than existing anti-cancer agents in blocking growth of tumor cells.
The parent compound called FR901464 and its analog called meayamycin inhibited the growth of cancer cells implanted into laboratory mice.
The compound has been described as one […]
By Gloria Gamat -- 0 comments
March 1st, 2007
I wasn’t prepared to talk about preparedness. See, today’s my first day and I had illusions of a “welcome me” post telling you (hopefully soon to be) loyal readers the back story that got me, your humble narrator, here.
Once I realized that the other bloggers here in the Science & Health were writing for […]
By Robin Dunn Bryant -- 3 comments
March 1st, 2007
A new class of targeted anti-cancer drugs – pertuzumab - has been found by a new Cedar-Sinai study to prolong the lives of patients with recurrent prostate cancer.
Pertuzumab works by blocking the human epidermal growth factor (HER) receptor family by binding to and inhibiting the function of HER2 receptors, thereby interrupting a key pathway leading […]
By Gloria Gamat -- 0 comments
Recent Comments